Myelodysplastic Syndrome

June 6, 2018

Updates in the Management of Myelodysplastic Syndromes

Charles H. Weaver, MD
June 2, 2018

Vidaza® Improves Survival in Myelodysplastic Syndromes

Charles H. Weaver, MD
June 1, 2018

Revlimid® Effective for Patients with Myelodysplastic Syndromes with Deletion

Charles H. Weaver, MD
June 1, 2018

AMG 531 May Be Effective in Treating Thrombocytopenia in Patients with MDS

Charles H. Weaver, MD
October 31, 2017

Erythropoietin Plus Granulocyte Macrophage Factor for Myelodysplastic Syndrome

Charles H. Weaver, MD
December 20, 2016

Anti-Inflammatory Drug Combination Appears to Improve Blood Counts for Persons

Charles H. Weaver, MD
January 13, 2015

Aggressive Chemotherapy Increases Remission in Patients with High-Risk MDS

Charles H. Weaver, MD
March 11, 2009

Autologous Stem Cell Transplants Prove Promising in Myelodysplastic Syndromes

Charles H. Weaver, MD
March 8, 2009

Further Evidence that Vidaza® Reduces Need for Transfusions in MDS

Charles H. Weaver, MD
March 8, 2009

Revlimid® Approved for Myelodysplastic Syndromes

Charles H. Weaver, MD
March 8, 2009

Thalidomide Effective for Myelodysplastic Syndrome

Charles H. Weaver, MD
March 8, 2009

Revlimid™ Effective for Low-Risk Myelodysplastic Syndromes

Charles H. Weaver, MD